Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
ProKidney Corp. (NASDAQ : PROK) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.
Quote
| Last: | $1.66 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $1.65 |
| Close: | $1.66 |
| High: | $1.715 |
| Low: | $1.61 |
| Volume: | 537,250 |
| Last Trade Date Time: | 06/12/2026 12:44:47 pm |
Stock Data
| Market Cap: | $604,677,102 |
|---|---|
| Float: | 98,372,842 |
| Insiders Ownership: | N/A |
| Institutions: | 82 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.prokidney.com |
| Country: | US |
| City: | Winston-Salem |
Recent News Releases
Subscribe to Our Newsletter
Message Board Posts
investorshub : The Law (f/k/a emz)
investorshub : BurgerKing82
investorshub : The Law (f/k/a emz)
investorshub : The Law (f/k/a emz)
**MWN-AI FAQ is based on asking OpenAI questions about ProKidney Corp. (NASDAQ: PROK).
